Biotage AB (publ) (STO:BIOT)
Sweden
· Delayed Price · Currency is SEK 141.80
+0.10 (0.07%)
May 30, 2025, 5:29 PM CET
Biotage AB Revenue
Biotage AB had revenue of 385.00M SEK in the quarter ending March 31, 2025, a decrease of -19.79%. This brings the company's revenue in the last twelve months to 1.96B, down -1.01% year-over-year. In the year 2024, Biotage AB had annual revenue of 2.06B with 10.42% growth.
Revenue (ttm)
1.96B
Revenue Growth
-1.01%
P/S Ratio
5.79
Revenue / Employee
3.15M
Employees
680
Market Cap
11.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.06B | 194.00M | 10.42% |
| Dec 31, 2023 | 1.86B | 296.00M | 18.90% |
| Dec 31, 2022 | 1.57B | 334.00M | 27.11% |
| Dec 31, 2021 | 1.23B | 140.00M | 12.82% |
| Dec 31, 2020 | 1.09B | -9.37M | -0.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Swedish Orphan Biovitrum AB | 26.24B |
| Sectra AB | 3.30B |
| Getinge AB | 35.57B |
| Asker Healthcare Group AB | 15.57B |
| Medicover AB | 23.56B |
| Camurus AB | 2.04B |
| AddLife AB | 10.42B |
| Vimian Group AB | 4.24B |
Biotage AB News
- 5 weeks ago - KKR makes $1.2 billion offer for Swedish life-sciences company Biotage - Seeking Alpha
- 5 weeks ago - KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage - The Wall Street Journal